BBOT
Price
$10.44
Change
+$0.05 (+0.48%)
Updated
Sep 15, 12:09 PM (EDT)
Capitalization
822.85M
79 days until earnings call
RAPP
Price
$23.65
Change
-$0.11 (-0.46%)
Updated
Sep 15, 12:39 PM (EDT)
Capitalization
1.1B
52 days until earnings call
Interact to see
Advertisement

BBOT vs RAPP

Header iconBBOT vs RAPP Comparison
Open Charts BBOT vs RAPPBanner chart's image
BridgeBio Oncology Therapeutics
Price$10.44
Change+$0.05 (+0.48%)
Volume$294
Capitalization822.85M
Rapport Therapeutics
Price$23.65
Change-$0.11 (-0.46%)
Volume$100
Capitalization1.1B
BBOT vs RAPP Comparison Chart in %
Loading...
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. RAPP commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 15, 2025
Stock price -- (BBOT: $10.39 vs. RAPP: $23.76)
Brand notoriety: BBOT and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 119% vs. RAPP: 235%
Market capitalization -- BBOT: $822.85M vs. RAPP: $1.1B
BBOT [@Biotechnology] is valued at $822.85M. RAPP’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than BBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 4 TA indicator(s) are bullish while RAPP’s TA Score has 6 bullish TA indicator(s).

  • BBOT’s TA Score: 4 bullish, 1 bearish.
  • RAPP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than BBOT.

Price Growth

BBOT (@Biotechnology) experienced а +4.95% price change this week, while RAPP (@Biotechnology) price change was +65.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

BBOT is expected to report earnings on Dec 03, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($1.1B) has a higher market cap than BBOT($823M). RAPP YTD gains are higher at: 33.935 vs. BBOT (-1.048). BBOT has higher annual earnings (EBITDA): -94.43M vs. RAPP (-100.79M). RAPP has more cash in the bank: 260M vs. BBOT (131M). BBOT has less debt than RAPP: BBOT (2.83M) vs RAPP (11.9M). BBOT (0) and RAPP (0) have equivalent revenues.
BBOTRAPPBBOT / RAPP
Capitalization823M1.1B75%
EBITDA-94.43M-100.79M94%
Gain YTD-1.04833.935-3%
P/E RatioN/A19.80-
Revenue00-
Total Cash131M260M50%
Total Debt2.83M11.9M24%
TECHNICAL ANALYSIS
Technical Analysis
BBOTRAPP
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
20%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
29%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
27%
Bullish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
26%
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
30%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 6 days ago
15%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLGYX40.64-0.10
-0.25%
Macquarie Large Cap Growth Fund Y
FIFPX25.71-0.08
-0.31%
Fidelity Advisor Founders M
EGOCX19.45-0.12
-0.61%
Allspring Large Cap Core C
RYGRX94.94-0.70
-0.73%
Rydex S&P 500 Pure Growth C
OCLVX20.14-0.15
-0.74%
Optimum Large Cap Value C

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and COCP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and COCP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
+2.16%
COCP - BBOT
25%
Poorly correlated
+9.72%
VKTX - BBOT
25%
Poorly correlated
-3.61%
RAPP - BBOT
23%
Poorly correlated
+2.41%
PRTC - BBOT
22%
Poorly correlated
-1.41%
SNGX - BBOT
22%
Poorly correlated
+5.04%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with PRAX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then PRAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+2.41%
PRAX - RAPP
35%
Loosely correlated
-4.35%
NUVB - RAPP
35%
Loosely correlated
-6.27%
FTRE - RAPP
35%
Loosely correlated
-1.27%
MLTX - RAPP
35%
Loosely correlated
-3.09%
DNLI - RAPP
32%
Poorly correlated
-4.25%
More